GENOMIC IMPRINTING and X-CHROMOSOME INACTIVATION in the GRAY, SHORT-TAILED OPOSSUM, MONODELPHIS DOMESTICA a Dissertation by KORY

Total Page:16

File Type:pdf, Size:1020Kb

GENOMIC IMPRINTING and X-CHROMOSOME INACTIVATION in the GRAY, SHORT-TAILED OPOSSUM, MONODELPHIS DOMESTICA a Dissertation by KORY GENOMIC IMPRINTING AND X-CHROMOSOME INACTIVATION IN THE GRAY, SHORT-TAILED OPOSSUM, MONODELPHIS DOMESTICA A Dissertation by KORY CHARLES DOUGLAS Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Paul B Samollow Committee Members, Scott Dindot Charles Long Keith Maggert Head of Department, Craig Coates December 2013 Major Subject: Genetics Copyright 2013 Kory Charles Douglas ABSTRACT Imprinted genes have been extensively documented in eutherian mammals and exhibit significant interspecific variation, both in the suites of genes that are imprinted and in their regulation between tissues and developmental stages. Much less is known about imprinted loci in metatherian (marsupial) mammals, wherein studies have been limited to a small number of genes imprinted in eutherians. In this dissertation, I used ChIP-seq and RNA-seq approaches to conduct the first ab initio search for imprinted autosomal genes in fibroblasts, fetal brain, and placenta of a metatherian mammal, the gray short-tailed opossum, Monodelphis domestica, and the first chromosome-wide study of paternally imprinted metatherian X chromosome inactivation. Evidence from a few genes in diverse species suggests that metatherian X- chromosome inactivation is characterized by exclusive, but incomplete (leaky), repression of genes on the paternally derived X chromosome. Herein I show that the majority of opossum X-linked genes exhibit paternally imprinted expression with 100% maternal-allele expression, whereas ~14% of genes escape inactivation, exhibiting varying levels of biallelic expression. In addition, I have shown that transcriptionally opposing histone modifications correlate strongly with opossum XCI. However, the opossum did not show an association between X-linked gene expression and promoter DNA methylation. In generating the first genome-wide profile of histone modification states for a metatherian mammal, and coupling it with in-depth gene expression analyses, I ii identified the first set of genes imprinted in a metatherian that are not imprinted in eutherian mammals and described transcriptionally opposing histone modifications and differential DNA methylation at the promoters of a subset of these genes. My findings suggest that metatherians use multiple epigenetic mechanisms to mark imprinted genes and support the concept that lineage-specific selective forces can produce sets of imprinted genes that differ between metatherian and eutherian lines. Overall, these studies furnish a comprehensive catalog of parent-of-origin expression status for both autosomal and X-linked genes in a metatherian, Monodelphis domestica, and open new avenues for illuminating the mechanisms and evolution of imprinted gene regulation in mammals generally. iii ACKNOWLEDGEMENTS I would like to thank my committee chair, Dr. Paul Samollow, and my committee members, Dr. Scott Dindot, Dr. Charles Long, and Dr. Keith Maggert for their guidance and support throughout the course of this research. I would also like to thank my many collaborators for their contributions to my work especially Madhuri Jasti as well as Dr. Andrew Clark and Dr. Xu Wang at Cornell University. Without their contributions, this work would not have been possible. I cannot thank my many colleagues at Texas A&M University enough for their willingness to celebrate the successes and help me to survive the struggles. Our many conversations and discussions have shaped me both personally and professionally, and I will always cherish our time together. Finally, I would like to thank my wife, Lauren, and son, William, for their patience, steadfastness, understanding, and love. I would also like to thank my family and friends for their unending support. iv TABLE OF CONTENTS Page ABSTRACT ..................................................................................................................... ii ACKNOWLEDGEMENTS .............................................................................................. iv TABLE OF CONTENTS ................................................................................................... v LIST OF FIGURES ......................................................................................................... vii LIST OF TABLES ............................................................................................................ ix CHAPTER I INTRODUCTION ....................................................................................... 1 1.1 Monodelphis domestica as a Model Organism ........................................................ 1 1.2 Genomic Imprinting ................................................................................................. 3 1.3 Occurrence of Imprinted Genes in Metatherian and Eutherian Mammals .............. 5 1.4 Genomic Imprinting in Other Species ..................................................................... 7 1.5 DNA Methylation and Imprinting Control .............................................................. 8 1.6 Histone Modifications and Imprinting Control ...................................................... 11 1.7 X-Chromosome Inactivation .................................................................................. 13 1.8 Specific Aims and Structure .................................................................................. 13 CHAPTER II PATERNALLY IMPRINTED X-CHROMOSOME INACTIVATION (XCI) AND ESCAPERS OF XCI ............................... 16 2.1 Introduction ............................................................................................................ 16 2.2 Results .................................................................................................................... 20 2.3 Discussion .............................................................................................................. 43 2.4 Methods ................................................................................................................. 51 CHAPTER III CHIP-SEQ IDENTIFIES THE FIRST MARSUPIAL-SPECIFIC IMRPINTED GENE ............................................................................... 54 3.1 Introduction ............................................................................................................ 54 3.2 Methods ................................................................................................................. 59 3.3 Results .................................................................................................................... 64 3.4 Discussion .............................................................................................................. 73 3.5 Conclusion ............................................................................................................. 79 v Page CHAPTER IV GENOMIC IMPRPINTING IN FETAL BRAIN AND EXTRA-EMBRYONIC MEMBRANES ............................................... 80 4.1 Introduction ............................................................................................................ 80 4.2 Results .................................................................................................................... 82 4.3 Conclusions and Future Work ............................................................................... 93 CHAPTER V EXTENDED METHODS ........................................................................ 97 5.1 Chapter II Extended Methods ................................................................................ 97 5.2 Chapter III Extended Methods ............................................................................. 109 CHAPTER VI CONCLUSIONS .................................................................................. 111 6.1 Detection of Autosomal and X-Linked Candidate-Imprinted Genes in M. domestica by Epigenetic Profiling ....................................................................... 111 6.2 Chromosome-Wide Characterization of Paternally Imprinted X-Chromosome Inactivation in M. domestica ............................................................................... 113 6.3 Autosomal Imprinted Genes in M. domestica ...................................................... 116 6.4 Conclusion ........................................................................................................... 121 REFERENCES .............................................................................................................. 122 APPENDIX A SUPPLEMENTAL FIGURES .............................................................. 139 APPENDIX B SUPPLEMENTAL TABLES ................................................................ 158 vi LIST OF FIGURES Page Figure 1. Locations and allelic expression profiles of genes on the opossum X chromosome in fetal brain and extra-embryonic membranes (EEM) ............ 21 Figure 2. Pyrosequencing analysis of maternally vs. paternally derived allele expression ratios for 24 imprinted X-inactivation escaper genes from in opossum female fetal brain and EEM ............................................................ 24 Figure 3. Comparison of paternal X-linked gene expression percentage and female/male expression ratios. ....................................................................... 28 Figure 4. Depletion of H3K27me3 marks at opossum XCI escaper genes ................... 31 Figure 5. Histone modification is correlated with maternal vs. paternal-allele expression
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • A Novel PLEKHA7 Interactor at Adherens Junctions
    Thesis PDZD11: a novel PLEKHA7 interactor at adherens junctions GUERRERA, Diego Abstract PLEKHA7 is a recently identified protein of the AJ that has been involved by genetic and genomic studies in the regulation of miRNA signaling and cardiac contractility, hypertension and glaucoma. However, the molecular mechanisms behind PLEKHA7 involvement in tissue physiology and pathology remain unknown. In my thesis I report novel results which uncover PLEKHA7 functions in epithelial and endothelial cells, through the identification of a novel molecular interactor of PLEKHA7, PDZD11, by yeast two-hybrid screening, mass spectrometry, co-immunoprecipitation and pulldown assays. I dissected the structural basis of their interaction, showing that the WW domain of PLEKHA7 binds to the N-terminal region of PDZD11; this interaction mediates the junctional recruitment of PDZD11, identifying PDZD11 as a novel AJ protein. I provided evidence that PDZD11 forms a complex with nectins at AJ, its PDZ domain binds to the PDZ-binding motif of nectins. PDZD11 stabilizes nectins promoting the early steps of junction assembly. Reference GUERRERA, Diego. PDZD11: a novel PLEKHA7 interactor at adherens junctions. Thèse de doctorat : Univ. Genève, 2016, no. Sc. 4962 URN : urn:nbn:ch:unige-877543 DOI : 10.13097/archive-ouverte/unige:87754 Available at: http://archive-ouverte.unige.ch/unige:87754 Disclaimer: layout of this document may differ from the published version. 1 / 1 UNIVERSITE DE GENÈVE FACULTE DES SCIENCES Section de Biologie Prof. Sandra Citi Département de Biologie Cellulaire PDZD11: a novel PLEKHA7 interactor at adherens junctions THÈSE Présentée à la Faculté des sciences de l’Université de Genève Pour obtenir le grade de Doctor ès science, mention Biologie par DIEGO GUERRERA de Benevento (Italie) Thèse N° 4962 GENÈVE Atelier d'impression Repromail 2016 1 Table of contents RÉSUMÉ ..................................................................................................................
    [Show full text]
  • Singh, Nat Commun 2018
    ARTICLE DOI: 10.1038/s41467-018-04112-z OPEN Widespread intronic polyadenylation diversifies immune cell transcriptomes Irtisha Singh1,2, Shih-Han Lee3, Adam S. Sperling4, Mehmet K. Samur4, Yu-Tzu Tai4, Mariateresa Fulciniti4, Nikhil C. Munshi4, Christine Mayr 3 & Christina S. Leslie1 Alternative cleavage and polyadenylation (ApA) is known to alter untranslated region (3ʹUTR) length but can also recognize intronic polyadenylation (IpA) signals to generate 1234567890():,; transcripts that lose part or all of the coding region. We analyzed 46 3ʹ-seq and RNA-seq profiles from normal human tissues, primary immune cells, and multiple myeloma (MM) samples and created an atlas of 4927 high-confidence IpA events represented in these cell types. IpA isoforms are widely expressed in immune cells, differentially used during B-cell development or in different cellular environments, and can generate truncated proteins lacking C-terminal functional domains. This can mimic ectodomain shedding through loss of transmembrane domains or alter the binding specificity of proteins with DNA-binding or protein–protein interaction domains. MM cells display a striking loss of IpA isoforms expressed in plasma cells, associated with shorter progression-free survival and impacting key genes in MM biology and response to lenalidomide. 1 Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 2 Tri-I Program in Computational Biology and Medicine, Weill Cornell Graduate College, New York, NY 10065, USA. 3 Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 4 Lebow Institute of Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
    [Show full text]
  • A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
    Article A SARS-CoV-2 protein interaction map reveals targets for drug repurposing https://doi.org/10.1038/s41586-020-2286-9 A list of authors and affiliations appears at the end of the paper Received: 23 March 2020 Accepted: 22 April 2020 A newly described coronavirus named severe acute respiratory syndrome Published online: 30 April 2020 coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than Check for updates 160,000 individuals and caused worldwide social and economic disruption1,2. There are no antiviral drugs with proven clinical efcacy for the treatment of COVID-19, nor are there any vaccines that prevent infection with SARS-CoV-2, and eforts to develop drugs and vaccines are hampered by the limited knowledge of the molecular details of how SARS-CoV-2 infects cells. Here we cloned, tagged and expressed 26 of the 29 SARS-CoV-2 proteins in human cells and identifed the human proteins that physically associated with each of the SARS-CoV-2 proteins using afnity-purifcation mass spectrometry, identifying 332 high-confdence protein–protein interactions between SARS-CoV-2 and human proteins. Among these, we identify 66 druggable human proteins or host factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in clinical trials and 28 are preclinical compounds). We screened a subset of these in multiple viral assays and found two sets of pharmacological agents that displayed antiviral activity: inhibitors of mRNA translation and predicted regulators of the sigma-1 and sigma-2 receptors.
    [Show full text]
  • Variation in Protein Coding Genes Identifies Information Flow
    bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 1 1 2 3 4 5 Variation in protein coding genes identifies information flow as a contributor to 6 animal complexity 7 8 Jack Dean, Daniela Lopes Cardoso and Colin Sharpe* 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Institute of Biological and Biomedical Sciences 25 School of Biological Science 26 University of Portsmouth, 27 Portsmouth, UK 28 PO16 7YH 29 30 * Author for correspondence 31 [email protected] 32 33 Orcid numbers: 34 DLC: 0000-0003-2683-1745 35 CS: 0000-0002-5022-0840 36 37 38 39 40 41 42 43 44 45 46 47 48 49 Abstract bioRxiv preprint doi: https://doi.org/10.1101/679456; this version posted June 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Animal complexity and information flow 2 1 Across the metazoans there is a trend towards greater organismal complexity. How 2 complexity is generated, however, is uncertain. Since C.elegans and humans have 3 approximately the same number of genes, the explanation will depend on how genes are 4 used, rather than their absolute number.
    [Show full text]
  • Comprehensive Evaluation of the Contribution of X Chromosome Genes To
    Author Manuscript Published OnlineFirst on January 20, 2011; DOI: 10.1158/1535-7163.MCT-10-0910 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Comprehensive Evaluation of the Contribution of X Chromosome Genes to Platinum Sensitivity Eric R. Gamazon1, Hae Kyung Im2, Peter H. O’Donnell3,4, Dana Ziliak3, Amy L. Stark5, Nancy J. Cox1, M. Eileen Dolan3,4 and Rong Stephanie Huang3,4* 1Section of Genetic Medicine, 3Section of Hematology-Oncology, Department of Medicine; 4Committee on Clinical Pharmacology and Pharmacogenomics; 2Department of Health Studies; and 5Department of Human Genetics, The University of Chicago, Chicago, IL, USA Running title: X chromosome effects on platinum sensitivity Keywords: platinum agents, X chromosome gene expression, population differences 1 Downloaded from mct.aacrjournals.org on September 27, 2021. © 2011 American Association for Cancer Research. Author Manuscript Published OnlineFirst on January 20, 2011; DOI: 10.1158/1535-7163.MCT-10-0910 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Acknowledgments of Research Support: This study is supported by NIH/NIGMS Pharmacogenomics of Anticancer Agents grant U01GM61393, and by the University of Chicago Breast Cancer SPORE grant P50 CA125183. RSH received support from NIH/NIGMS grant K08GM089941, University of Chicago Cancer Center Support Grant (#P30 CA14599), and Breast Cancer SPORE Career Development Award. *To whom requests for reprints should be addressed,
    [Show full text]
  • Dynamic Erasure of Random X-Chromosome Inactivation During Ipsc Reprogramming
    bioRxiv preprint doi: https://doi.org/10.1101/545558; this version posted February 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Dynamic Erasure of Random X-Chromosome Inactivation during iPSC Reprogramming Adrian Janiszewski1,*, Irene Talon1,*, Juan Song1, Natalie De Geest1, San Kit To1, Greet Bervoets2,3, Jean-Christophe Marine2,3, Florian Rambow2,3, Vincent Pasque1,✉. 1 KU Leuven - University of Leuven, Department of Development and Regeneration, Herestraat 49, B-3000 Leuven, Belgium. 2 Laboratory for Molecular Cancer Biology, VIB Center for Cancer Biology 3 Department of Oncology, KU Leuven, Belgium ✉ Correspondence to: [email protected] (V.P.) * These authors contributed equally Format: Research paper ABSTRACT Background: Induction and reversal of chromatin silencing is critical for successful development, tissue homeostasis and the derivation of induced pluripotent stem cells (iPSCs). X-chromosome inactivation (XCI) and reactivation (XCR) in female cells represent chromosome-wide transitions between active and inactive chromatin states. While XCI has long been studied and provided important insights into gene regulation, the dynamics and mechanisms underlying the reversal of stable chromatin silencing of X-linked genes are much less understood. Here, we use allele- specific transcriptomic approaches to study XCR during mouse iPSC reprogramming in order to elucidate the timing and mechanisms of chromosome-wide reversal of gene silencing. Results: We show that XCR is hierarchical, with subsets of genes reactivating early, late and very late.
    [Show full text]
  • Co-Expression Network Analysis Identifies a Gene Signature As A
    Zhu et al. Cancer Cell Int (2020) 20:259 https://doi.org/10.1186/s12935-020-01352-2 Cancer Cell International PRIMARY RESEARCH Open Access Co-expression network analysis identifes a gene signature as a predictive biomarker for energy metabolism in osteosarcoma Naiqiang Zhu1* , Jingyi Hou2, Guiyun Ma1, Shuai Guo1, Chengliang Zhao1 and Bin Chen1 Abstract Background: Osteosarcoma (OS) is a common malignant bone tumor originating in the interstitial tissues and occur- ring mostly in adolescents and young adults. Energy metabolism is a prerequisite for cancer cell growth, proliferation, invasion, and metastasis. However, the gene signatures associated with energy metabolism and their underlying molecular mechanisms that drive them are unknown. Methods: Energy metabolism-related genes were obtained from the TARGET database. We applied the “NFM” algo- rithm to classify putative signature gene into subtypes based on energy metabolism. Key genes related to progression were identifed by weighted co-expression network analysis (WGCNA). Based on least absolute shrinkage and selec- tion operator (LASSO) Cox proportional regression hazards model analyses, a gene signature for the predication of OS progression and prognosis was established. Robustness and estimation evaluations and comparison against other models were used to evaluate the prognostic performance of our model. Results: Two subtypes associated with energy metabolism was determined using the “NFM” algorithm, and signif- cant modules related to energy metabolism were identifed by WGCNA. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) suggested that the genes in the signifcant modules were enriched in kinase, immune metabolism processes, and metabolism-related pathways. We constructed a seven-gene signature consisting of SLC18B1, RBMXL1, DOK3, HS3ST2, ATP6V0D1, CCAR1, and C1QTNF1 to be used for OS progression and prognosis.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumo
    cancers Article Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma Thomas Mohr 1,2 , Sonja Katz 1 , Verena Paulitschke 3 , Nadim Aizarani 4 and Alexander Tolios 5,6,7,∗ 1 ScienceConsult—DI Thomas Mohr KG, Enzianweg 10a, A-2353 Guntramsdorf, Austria; [email protected] or [email protected] (T.M.); [email protected] (S.K.) 2 Institute of Cancer Research, Department of Medicine I, Medical University of Vienna and Comprehensive Cancer Center, A-1090 Vienna, Austria 3 Department of Dermatology, Medical University of Vienna, A-1090 Vienna, Austria; [email protected] 4 Max-Planck-Institute of Immunobiology and Epigenetics, D-79108 Freiburg, Germany; [email protected] 5 Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, A-1090 Vienna, Austria 6 Center of Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, A-1090 Vienna, Austria 7 Section of Artificial Intelligence and Decision Support, Center for Medical Statistics, Informatics and Citation: Mohr, T.; Katz, S.; Intelligent Systems, Medical University of Vienna, A-1090 Vienna, Austria Paulitschke, V.; Aizarani, N.; Tolios, * Correspondence: [email protected] A. Systematic Analysis of the Transcriptome Profiles and Simple Summary: Endothelial cells, the innermost layer of blood vessels, play an essential role in the Co-Expression Networks of Tumour progression of cancer, particularly liver cancer. To develop cancer therapies targeting those cells, the Endothelial Cells Identifies Several investigation of gene co-expression networks is of great importance.
    [Show full text]
  • Tissue-Based Alzheimer Gene Expression Markers–Comparison Of
    Scheubert et al. BMC Bioinformatics 2012, 13:266 http://www.biomedcentral.com/1471-2105/13/266 RESEARCH ARTICLE Open Access Tissue-based Alzheimer gene expression markers–comparison of multiple machine learning approaches and investigation of redundancy in small biomarker sets Lena Scheubert1,3, Mitja Lustrekˇ 2, Rainer Schmidt3, Dirk Repsilber4* and Georg Fuellen3,5* Abstract Background: Alzheimer’s disease has been known for more than 100 years and the underlying molecular mechanisms are not yet completely understood. The identification of genes involved in the processes in Alzheimer affected brain is an important step towards such an understanding. Genes differentially expressed in diseased and healthy brains are promising candidates. Results: Based on microarray data we identify potential biomarkers as well as biomarker combinations using three feature selection methods: information gain, mean decrease accuracy of random forest and a wrapper of genetic algorithm and support vector machine (GA/SVM). Information gain and random forest are two commonly used methods. We compare their output to the results obtained from GA/SVM. GA/SVM is rarely used for the analysis of microarray data, but it is able to identify genes capable of classifying tissues into different classes at least as well as the two reference methods. Conclusion: Compared to the other methods, GA/SVM has the advantage of finding small, less redundant sets of genes that, in combination, show superior classification characteristics. The biological significance of the genes and gene pairs is discussed. Background could help both understanding the causes of the disease as Sporadic Alzheimer’s disease [1] is the most common well as suggest treatment options.
    [Show full text]
  • Article (Published Version)
    Article Cooperative binding of the tandem WW domains of PLEKHA7 to PDZD11 promotes conformation-dependent interaction with tetraspanin 33 ROUAUD, Florian, et al. Abstract Pleckstrin homology domain-containing A7 (PLEKHA7) is a cytoplasmic protein at adherens junctions that has been implicated in hypertension, glaucoma, and responses to Staphylococcus aureus α-toxin. Complex formation between PLEKHA7, PDZ domain-containing 11 (PDZD11), tetraspanin 33, and the α-toxin receptor ADAM metallopeptidase domain 10 (ADAM10) promotes junctional clustering of ADAM10 and α-toxin-mediated pore formation. However, how the N-terminal region of PDZD11 interacts with the N-terminal tandem WW domains of PLEKHA7 and how this interaction promotes tetraspanin 33 binding to the WW1 domain is unclear. Here, we used site-directed mutagenesis, glutathione S-transferase pulldown experiments, immunofluorescence, molecular modeling, and docking experiments to characterize the mechanisms driving these interactions. We found that Asp-30 of WW1 and His-75 of WW2 interact through a hydrogen bond and, together with Thr-35 of WW1, form a binding pocket that accommodates a polyproline stretch within the N-terminal PDZD11 region. By strengthening the interactions of the ternary complex, the WW2 domain stabilized the WW1 [...] Reference ROUAUD, Florian, et al. Cooperative binding of the tandem WW domains of PLEKHA7 to PDZD11 promotes conformation-dependent interaction with tetraspanin 33. Journal of Biological Chemistry, 2020, vol. 295, no. 28, p. 9299-9312 DOI : 10.1074/jbc.RA120.012987
    [Show full text]